Friday, December 6, 2019 - 11:13
Sofia, Bulgaria, December 5, 2019 - Sopharma AD (3JR: “BSE-Sofia” AD, SPH: Warsaw Stock Exchange) notifies that for November 2019 the Company recorded an increase in sales of 24% compared to the same month of 2018, incl. 21% increase in sales for the domestic market and 27% increase in export sales.
In the first eleven months of 2019 the revenues from sales of production increased by 8% compared to the same period of 2018, incl. 1% decrease in domestic sales and 14% increase in export sales.